Labcorp Holdings Inc. (LH)

LH Income Statement

Revenue, expenses, and profitability analysis

LH Quarterly Income Statement (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Revenue	14.144B	3.538B	3.516B	3.563B	3.527B	3.345B	3.329B	3.282B	3.221B
Cost of Goods Sold	10.214B	2.599B	2.595B	2.538B	2.481B	2.397B	2.433B	2.378B	2.295B
Gross Profit	3.930B	938.200M	920.600M	1.025B	1.046B	948.000M	896.300M	904.400M	926.400M
Gross Profit Margin	26.5%	26.5%	26.2%	28.8%	29.7%	28.3%	26.9%	27.6%	28.8%
Total Operating Expenses	2.370B	551.000M	538.600M	628.500M	651.700M	622.000M	679.800M	650.300M	631.600M
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	2.221B	551.000M	538.600M	552.400M	579.300M	546.000M	595.200M	568.600M	557.800M
Operating Income (EBIT)	1.560B	387.200M	382.000M	396.600M	394.500M	326.000M	216.500M	254.100M	294.800M
Operating Margin	10.9%	10.9%	10.9%	11.1%	11.2%	9.7%	6.5%	7.7%	9.2%
Income Before Tax (EBT)	1.152B	319.700M	190.600M	337.000M	304.700M	275.200M	183.800M	210.600M	267.700M
Interest Income	17.400M	12.200M	3.500M	—	1.700M	—	—	—	—
Interest Expense	223.200M	55.100M	55.000M	56.000M	57.100M	56.000M	63.400M	50.400M	47.600M
Other Income/Expense	-408.300M	-67.500M	-191.400M	-59.600M	-89.800M	-50.800M	-32.700M	-43.500M	-27.100M
Net Income	941.500M	277.800M	164.700M	261.100M	237.900M	212.800M	143.400M	169.300M	205.300M
Income Tax Expense	209.300M	41.700M	25.700M	75.500M	66.400M	62.200M	40.200M	41.000M	62.100M
Net Profit Margin	7.9%	7.9%	4.7%	7.3%	6.7%	6.4%	4.3%	5.2%	6.4%
EBITDA	2.063B	548.100M	418.600M	564.000M	532.100M	498.000M	417.800M	422.500M	472.200M
EBITDA Margin	15.5%	15.5%	11.9%	15.8%	15.1%	14.9%	12.5%	12.9%	14.7%
Depreciation & Amortization	687.600M	173.300M	173.000M	171.000M	170.300M	166.800M	170.600M	161.500M	156.900M
EPS Basic	11.37	3.37	2.00	3.14	2.86	2.54	1.72	2.02	2.44
EPS Diluted	11.29	3.35	1.98	3.12	2.84	2.52	1.70	2.01	2.44
Shares Outstanding	82.300M	82.300M	82.500M	83.100M	83.500M	83.600M	83.600M	84.000M	84.100M
Diluted Shares Outstanding	82.900M	82.900M	83.200M	83.700M	84.100M	84.300M	84.200M	84.400M	84.300M

LH Annual Income Statement (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	13.952B	13.009B	12.162B	11.864B	13.136B	13.979B	11.555B	11.333B
Cost of Goods Sold	10.219B	9.384B	8.797B	8.155B	8.144B	9.026B	8.302B	8.157B
Gross Profit	3.732B	3.624B	3.365B	3.709B	4.992B	4.953B	3.252B	3.176B
Gross Profit Margin	26.8%	27.9%	27.7%	31.3%	38.0%	35.4%	28.1%	28.0%
Total Operating Expenses	2.216B	2.538B	2.639B	2.272B	1.944B	2.507B	1.868B	1.803B
Research & Development	0.00	0.00	2.000M	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	2.216B	2.230B	2.021B	1.997B	1.690B	1.729B	1.625B	1.571B
Operating Income (EBIT)	1.516B	1.087B	725.600M	1.437B	3.049B	2.445B	1.330B	1.326B
Operating Margin	10.9%	8.4%	6.0%	12.1%	23.2%	17.5%	11.5%	11.7%
Income Before Tax (EBT)	1.107B	959.500M	568.900M	1.237B	2.888B	2.219B	1.105B	1.268B
Interest Income	15.200M	—	—	—	—	—	—	—
Interest Expense	224.100M	208.300M	199.600M	179.800M	211.800M	207.400M	240.700M	244.200M
Other Income/Expense	-408.700M	-127.200M	-156.700M	-199.100M	-161.000M	-226.300M	-225.300M	-57.400M
Net Income	876.500M	746.000M	418.000M	1.279B	2.377B	1.556B	823.800M	883.700M
Income Tax Expense	229.800M	212.400M	188.500M	233.900M	690.000M	662.100M	280.000M	384.400M
Net Profit Margin	6.3%	5.7%	3.4%	10.8%	18.1%	11.1%	7.1%	7.8%
EBITDA	2.013B	1.811B	1.349B	1.954B	3.676B	3.252B	2.117B	2.065B
EBITDA Margin	14.4%	13.9%	11.1%	16.5%	28.0%	23.3%	18.3%	18.2%
Depreciation & Amortization	681.100M	643.500M	577.300M	537.200M	577.000M	825.000M	771.300M	552.100M
EPS Basic	10.54	8.89	4.80	14.04	24.58	15.99	8.41	8.71
EPS Diluted	10.46	8.84	4.77	13.96	24.38	15.88	8.36	8.61
Shares Outstanding	83.200M	83.900M	87.100M	91.100M	96.700M	97.300M	97.900M	101.400M
Diluted Shares Outstanding	83.800M	84.400M	87.600M	91.600M	97.500M	98.000M	98.600M	102.600M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC

60,900 employees

www.labcorp.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Adam H. Schechter

View full financials